StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Piper Sandler on Abbott Labs (ABT): 'A Name Worth Revisiting'
June 22, 2026 9:45 AM
Piper Sandler analyst Adam Maeder reiterated an Overweight rating and $115.00 price target on Abbott Labs (NYSE: ABT).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
